Medical
Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug
The US FDA has approved Elacestrant, the first oral selective estrogen receptor degrader (SERD), for the treatment of patients with advanced or metastatic breast cancer who are estrogen receptor positive, HER2 negative and have an ESR1 mutation. Results of the trial showed that patients treated with Elacestrant had a 45% reduction in the risk of disease progression or death.
Disease
How to prevent urinary incontinence?
Urinary incontinence, also known as incontinence, is a disease in which urine flows out involuntarily due to the loss of urinary self-control due to bladder sphincter injury or neurological dysfunction. Because female urethra is shorter than male urethra and has no physiological curvature, and women also shoulder the responsibility of pregnancy and childbirth, urinary incontinence is more common in middle-aged and elderly women.
Hospital
Christie Hospital, UK
Christie Hospital, based in Manchester, is one of the top three cancer centres in Europe, with 2,500 staff, 300 volunteers and 30,000 members, treating over 44,000 patients each year
University of Chicago Medical Center
The University of Chicago Medical Center is one of the nation's leading academic medical institutions, home to the University of Chicago, which has been among the top 10 universities in the world for many years, has produced 92 Nobel Prize winners, including 12 in physiology or medicine, and has been at the forefront of global healthcare.
Medipolis Proton Therapy Centre, Japan
Medipolis Proton Therapy Centre Japan, located in Kagoshima, Kyushu, Japan, is one of the few JCI (Joint Commission International accredited high standard treatment facilities) accredited proton centres in the world.